Helpline
Call 1.855.378.4373 to schedule a call time with a specialist or visit scheduler.drugfree.org
Helpline

E-Cigarettes & Vaping

A bill that would make New York the first state to ban the sale of e-cigarettes appears unlikely to pass, the Associated Press reports.

Tobacco manufacturer Lorillard has purchased a company that makes electronic cigarettes. This is the first foray by a major tobacco company into the small, but quickly expanding, market of e-cigarettes, according to The Wall Street Journal.

Laws regulating e-cigarettes are under consideration in a growing number of states, The Wall Street Journal reports.

Princess Cruise Lines will ban smoking in its staterooms and balconies starting Monday. While more cruise lines are banning cigarettes, policies on e-cigarettes vary among the cruise lines, the Sun-Sentinel reports.

A new report concludes the Food and Drug Administration needs more information about the health effects of “modified risk” tobacco products such as e-cigarettes or tobacco lozenges, before it allows tobacco companies to sell or advertise these products as being able to reduce the health risks of tobacco use.

The role of electronic cigarettes in helping people quit smoking is stirring debate, according to The New York Times.

Electronic cigarettes, or e-cigarettes, are slowly becoming more popular with retailers, Convenience Store News reports. Many retailers continue to take a “wait and see” approach to the products, before deciding whether to assign them shelf space.

The U.S. Department of Transportation has proposed a rule that would ban smoking electronic cigarettes on all domestic and international commercial flights.

Electronic cigarettes, or “e-cigarettes,” are crude drug delivery systems for refined nicotine that pose unknown risks, two experts write in this week’s New England Journal of Medicine.

The U.S. Food and Drug Administration (FDA) announced it will regulate smokeless electronic cigarettes as tobacco products, treating them the same as traditional cigarettes. The decision comes after the FDA lost a court case in which it argued that the devices should be regulated as drug-delivery devices, which must satisfy stricter requirements.

1 9 10 11